Evidence map›Paper›PMID 33144057›Full record

ArticleOral oncology2021

Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic.

Mohammed Imaduddin, Mahesh Sultania, B Vigneshwaran, Dillip Kumar Muduly, Madhabananda Kar

Open access · greenAbstract readLetterComment
In one paragraph

Article in Oral oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohammed ImaduddinDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Mahesh SultaniaDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. Electronic address: drmaheshsultania@gmail.com.
B VigneshwaranDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Dillip Kumar MudulyDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Madhabananda KarDepartment of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
All India Institute of Medical Sciences Bhubaneswar · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinomaCOVID-19Mouth NeoplasmsCelecoxibCisplatinHumansMethotrexateNeoplasm Recurrence, LocalPandemicsSARS-CoV-2CelecoxibCisplatinMethotrexate

Identifiers

PMID33144057
PMCPMC7584917
OpenAlexW3093939583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.